ETF Managers Group, LLC Alnylam Pharmaceuticals, Inc. Transaction History

ETF Managers Group, LLC

$2.78 Billion
Q1 2023

A detailed history of ETF Managers Group, LLC transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, ETF Managers Group, LLC holds 10,382 shares of ALNY stock, worth $2.85 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

10,382

Previous 11,124 6.67%

Holding current value

$2.85 Million

Previous $2.64 Million 21.34%

% of portfolio

0.07%

Previous 0.13%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 17, 2023	SELL	$182.66 - $235.53 $135,533 - $174,763	-742 Reduced 6.67%	10,382 $2.08 Million
Q4 2022 Mar 23, 2023	SELL	$185.53 - $241.31 $16,697 - $21,717	-90 Reduced 0.8%	11,124 $2.64 Million
Q3 2022 Nov 14, 2022	SELL	$138.54 - $232.0 $3.32 Million - $5.56 Million	-23,965 Reduced 68.12%	11,214 $2.25 Million
Q2 2022 Aug 15, 2022	BUY	$120.42 - $169.29 $2.2 Million - $3.09 Million	18,279 Added 108.16%	35,179 $5.12 Million
Q1 2022 May 13, 2022	SELL	$127.18 - $173.91 $684,101 - $935,461	-5,379 Reduced 24.14%	16,900 $2.79 Million
Q4 2021 Feb 14, 2022	SELL	$159.56 - $209.29 $546,173 - $716,399	-3,423 Reduced 13.32%	22,279 $3.81 Million
Q3 2021 Nov 15, 2021	BUY	$169.75 - $207.73 $1.16 Million - $1.42 Million	6,822 Added 36.13%	25,702 $4.56 Million
Q2 2021 Aug 16, 2021	SELL	$128.63 - $176.89 $1.02 Million - $1.4 Million	-7,892 Reduced 29.48%	18,880 $3.13 Million
Q1 2021 May 17, 2021	BUY	$126.83 - $175.69 $896,561 - $1.24 Million	7,069 Added 35.88%	26,772 $3.62 Million
Q4 2020 Feb 16, 2021	BUY	$122.97 - $147.0 $169,698 - $202,860	1,380 Added 7.53%	19,703 $2.58 Million
Q3 2020 Nov 16, 2020	BUY	$121.19 - $165.49 $965,399 - $1.32 Million	7,966 Added 76.91%	18,323 $2.66 Million
Q2 2020 Aug 14, 2020	BUY	$104.21 - $156.44 $772,717 - $1.16 Million	7,415 Added 252.04%	10,357 $1.53 Million
Q1 2020 May 14, 2020	BUY	$93.12 - $133.99 $27,936 - $40,197	300 Added 11.36%	2,942 $320,000
Q4 2019 Feb 14, 2020	BUY	$74.51 - $124.23 $45,227 - $75,407	607 Added 29.83%	2,642 $303,000
Q3 2019 Nov 14, 2019	SELL	$70.9 - $87.82 $5,175 - $6,410	-73 Reduced 3.46%	2,035 $165,000
Q2 2019 Aug 14, 2019	BUY	$65.86 - $92.79 $59,669 - $84,067	906 Added 75.37%	2,108 $150,000
Q1 2019 May 07, 2019	BUY	$72.76 - $93.45 $8,440 - $10,840	116 Added 10.68%	1,202 $112,000
Q4 2018 Feb 01, 2019	BUY	$62.67 - $88.33 $9,212 - $12,984	147 Added 15.65%	1,086 $79,000
Q3 2018 Nov 14, 2018	BUY	$87.52 - $122.67 $8,576 - $12,021	98 Added 11.65%	939 $82,000
Q2 2018 Aug 14, 2018	SELL	$88.31 - $107.8 $46,627 - $56,918	-528 Reduced 38.57%	841 $66,000
Q1 2018 May 15, 2018	BUY	$115.92 - $148.54 $19,706 - $25,251	170 Added 14.18%	1,369 $139,000
Q4 2017 Feb 14, 2018	BUY	$114.49 - $139.98 $19,463 - $23,796	170 Added 16.52%	1,199 $158,000
Q3 2017 Nov 14, 2017	BUY	$72.53 - $118.27 $74,633 - $121,699	1,029	1,029 $121,000

Others Institutions Holding ALNY

# of Institutions

614

Shares Held

108M

Call Options Held

2.33M

Put Options Held

2.17M

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $33.8B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of ETF Managers Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on ETF Managers Group, LLC with notifications on news.

Account

ETF Managers Group, LLC Alnylam Pharmaceuticals, Inc. Transaction History